Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-SARS-CoV-2 Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04521400
What this trial is testing

The Investigation Into Beneficial Effects of High-dose Interferon Beta 1-a, Compared to Low-dose Interferon Beta 1-a in Moderate to Severe Covid-19

Who this might be right for
Covid19
Shahid Beheshti University of Medical Sciences 100
Testing effectiveness (Phase 2)UnknownNCT04573855
What this trial is testing

TREATMENT WITH ANTI-SARS-COV-2 IMMUNOGLOBULIN IN PATIENTS WITH COVID-19

Who this might be right for
Covid19
D'Or Institute for Research and Education 41
Not applicableStudy completedNCT04852796
What this trial is testing

Efficacy and Safety of the Anti- COVID-19 Vaccin in Clinical Hematology Patients

Who this might be right for
Covid19Hematologic MalignancyVaccine Response Impaired
Centre Hospitalier de Cornouaille 1,000
Not applicableStudy completedNCT06753942
What this trial is testing

ANTI-SARS-CoV-2 SEROCONVERSIO IN IMMUNE-MEDIATED KIDNEY DISEASES

Who this might be right for
Immune-mediated DiseasesGlomerulonephritis
IRCCS Azienda Ospedaliero-Universitaria di Bologna 120
Large-scale testing (Phase 3)UnknownNCT04558021
What this trial is testing

Evaluate The Efficacy And Safety Of a Novel Niclosamide Suspension Formulation For COVID-19

Who this might be right for
Covid19
Imuneks Farma ilac San. Tic. A.S. 200
Not applicableStudy completedNCT04453501
What this trial is testing

Anti Infective Agents Impact in COVID-19 Pneumonia

Who this might be right for
COVIDPneumonia, Viral
Centre d'Investigation Clinique et Technologique 805 132
Large-scale testing (Phase 3)UnknownNCT04838821
What this trial is testing

Efficacy and Safety of Three Different Doses of an Anti SARS-CoV-2 Hyperimmune Equine Serum in COVID-19 Patients

Who this might be right for
Covid19
Caja Costarricense de Seguro Social 156
Not applicableUnknownNCT04924829
What this trial is testing

Safety and Effectiveness Study of Tocilizumab in Patients With Severe COVID-19

Who this might be right for
Severe COVID 19 PneumoniaTocilizumab
Hospital Italiano de Buenos Aires 300
Not applicableStudy completedNCT04733105
What this trial is testing

Pronostic Value of Type I ANTi-Interferon Antibodies in Patients With COVID-19 Acute Respiratory Failure

Who this might be right for
Acute Respiratory Failure
Assistance Publique - Hôpitaux de Paris 1,022
Very early researchStudy completedNCT05595538
What this trial is testing

Use of Multiple Doses of Convalescent Plasma in Mechanically Intubated Patients With COVID-19

Who this might be right for
COVID-19
Hospital Regional Dr. Rafael Estévez 30
Not applicableUnknownNCT04383548
What this trial is testing

Clinical Study for Efficacy of Anti-Corona VS2 Immunoglobulins Prepared From COVID19 Convalescent Plasma Prepared by VIPS Mini-Pool IVIG Medical Devices in Prevention of SARS-CoV-2 Infection in High Risk Groups as Well as Treatment of Early Cases of COVID19 Patients

Who this might be right for
COVID19
Assiut University 100
Large-scale testing (Phase 3)Study completedNCT04728802
What this trial is testing

Proxalutamide Treatment for Hospitalized COVID-19 Patients

Who this might be right for
Covid19SARS (Severe Acute Respiratory Syndrome)
Applied Biology, Inc. 645
Not applicableStudy completedNCT06334744
What this trial is testing

Ambispective Observational Multicenter Study on the Efficacy of the Third Dose of Vaccine Anti COVID-19 in Patients Suffering From Solid Tumors Undergoing Oncological Treatment Active.

Who this might be right for
Oncologic Complications
Fondazione IRCCS Policlinico San Matteo di Pavia 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT05877508
What this trial is testing

Anti-SARS-CoV-2 Monoclonal Antibodies for Long COVID (COVID-19)

Who this might be right for
Long COVIDPost-Acute Sequela of COVID-19Post-Acute COVID-19
Michael Peluso, MD 36
Early research (Phase 1)Study completedNCT04932850
What this trial is testing

Study to Evaluate the Safety and Concentrations of Monoclonal Antibody Against Virus That Causes COVID-19 Disease.

Who this might be right for
COVID-19 Virus Disease
Toscana Life Sciences Sviluppo s.r.l. 30
Not applicableUnknownNCT05258708
What this trial is testing

COVID-19 Vaccine Reactogenicity and Immunogenicity

Who this might be right for
COVID-19Vaccine Immune ResponseVaccine Adverse Reaction
Korea University Guro Hospital 179
Large-scale testing (Phase 3)UnknownNCT04321616
What this trial is testing

The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients

Who this might be right for
SARS-CoV InfectionCOVID 19Acute Respiratory Distress Syndrome ARDS
Oslo University Hospital 700
Not applicableLooking for participantsNCT06168032
What this trial is testing

COVID-19 Vaccine Effectiveness Against Recurrent Infection Among Lung Cancer Patients and Biomarker Research

Who this might be right for
COVID-19 RecurrentLung CancerVaccination+3 more
Peking Union Medical College Hospital 1,224
Not applicableStudy completedNCT04530682
What this trial is testing

COVID-19 in Rheumatic Inflammatory Diseases Under Immuno-suppressive Drugs

Who this might be right for
Chronic Inflammatory Rheumatism
University Hospital, Montpellier 163
Not applicableStudy completedNCT05419206
What this trial is testing

The Relationship Between CMV* Reactivation and Anti-cytokine Treatment in Critical COVID-19 Patients

Who this might be right for
COVID-19, Cytomegalovirus (CMV), Tocilizumab, Anakinra, Mortality
Ramazan Gozukucuk 167
Next Page